Portfolio Holdings Detail for ISIN IE00BKTLJC87

Stock Name / Fund	iShares Smart City Infrastructure UCITS ETF USD (Acc)
Issuer	Blackrock
Entity holding fund	iShares IV Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300ZP07LMR36K1T02
ETF Ticker	AYEU(EUR) F
ETF Ticker	AYEU.DE(EUR) CXE
ETF Ticker	CISBz(USD) CXE
ETF Ticker	CITY.AS(USD) CXE
ETF Ticker	CITY.MI(EUR) CXE
ETF Ticker	CITY.PA(EUR) CXE
ETF Ticker	CITY(EUR) ETF Plus

Holdings detail for MLAB

Show aggregate MLAB holdings

News associated with MLAB

Implied VIOO Analyst Target Price: $124

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-19 08:09:35

Choreo LLC Decreases Position in Mesa Laboratories, Inc. (NASDAQ:MLAB)

Choreo LLC lowered its stake in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) by 3.3% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,887 shares of the medical instruments supplier’s stock after selling 165 shares during the quarter. Choreo LLC owned 0.09% […] - 2025-07-28 05:46:54

Bank of New York Mellon Corp Boosts Holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB)

Bank of New York Mellon Corp lifted its stake in Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) by 2.7% during the first quarter, Holdings Channel reports. The institutional investor owned 54,767 shares of the medical instruments supplier’s stock after acquiring an additional 1,463 shares during the quarter. Bank of New York Mellon Corp’s holdings in […] - 2025-07-24 04:20:52

Mesa Laboratories (NASDAQ:MLAB) Downgraded by Wall Street Zen to “Buy”

Wall Street Zen lowered shares of Mesa Laboratories (NASDAQ:MLAB – Free Report) from a strong-buy rating to a buy rating in a research note issued to investors on Friday morning. Separately, Wells Fargo & Company decreased their price target on Mesa Laboratories from $120.00 to $100.00 and set an “underweight” rating on the stock in […] - 2025-06-02 04:20:57

Ameriprise Financial Inc. Acquires 99,819 Shares of Mesa Laboratories, Inc. (NASDAQ:MLAB)

Ameriprise Financial Inc. boosted its holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) by 191.8% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 151,862 shares of the medical instruments supplier’s stock after purchasing an additional 99,819 shares during the period. Ameriprise Financial Inc.’s holdings in Mesa Laboratories were worth $20,026,000 as of […] - 2025-05-16 05:01:15

Implied IJT Analyst Target Price: $153

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-15 07:40:17

Mesa Laboratories, Inc. (NASDAQ:MLAB) Shares Sold by Dimensional Fund Advisors LP

Dimensional Fund Advisors LP trimmed its position in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) by 7.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 113,850 shares of the medical instruments supplier’s stock after selling 9,723 shares during the […] - 2025-05-09 05:02:47

Short Interest in Mesa Laboratories, Inc. (NASDAQ:MLAB) Rises By 20.1%

Mesa Laboratories, Inc. (NASDAQ:MLAB – Get Free Report) was the recipient of a large increase in short interest in April. As of April 15th, there was short interest totalling 224,300 shares, an increase of 20.1% from the March 31st total of 186,700 shares. Based on an average trading volume of 44,100 shares, the short-interest ratio […] - 2025-05-05 05:30:49

Mesa Laboratories, Inc. (NASDAQ:MLAB) Stake Decreased by CANADA LIFE ASSURANCE Co

CANADA LIFE ASSURANCE Co reduced its holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) by 7.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 6,927 shares of the medical instruments supplier’s stock after selling 577 shares during the quarter. […] - 2025-04-30 05:44:12

Analysts Expect SPTM To Hit $83

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-04-02 08:02:55

Choreo LLC Grows Stock Holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB)

Choreo LLC lifted its position in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) by 38.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 5,052 shares of the medical instruments supplier’s stock after purchasing an additional 1,392 shares during […] - 2025-02-11 06:46:52

Mesa Laboratories (NASDAQ:MLAB) Shares Up 12.3% After Better-Than-Expected Earnings

Mesa Laboratories, Inc. (NASDAQ:MLAB – Get Free Report)’s stock price was up 12.3% during mid-day trading on Tuesday after the company announced better than expected quarterly earnings. The stock traded as high as $143.94 and last traded at $150.43. Approximately 4,303 shares changed hands during trading, a decline of 85% from the average daily volume […] - 2025-02-06 04:08:53

Mesa Laboratories (NASDAQ:MLAB) Hits New 12-Month High After Earnings Beat

Mesa Laboratories, Inc. (NASDAQ:MLAB – Get Free Report)’s stock price reached a new 52-week high on Wednesday following a stronger than expected earnings report. The company traded as high as $152.75 and last traded at $137.27, with a volume of 68479 shares traded. The stock had previously closed at $133.93. The medical instruments supplier reported […] - 2025-02-05 04:40:49

iShares Smart City Infrastructure UCITS ETF USD (Acc) MLAB holdings

Date	Number of MLAB Shares Held	Base Market Value of MLAB Shares	Local Market Value of MLAB Shares	Change in MLAB Shares Held	Change in MLAB Base Value	Current Price per MLAB Share Held	Previous Price per MLAB Share Held
2026-02-10 (Tuesday)	3,942	USD 362,467	USD 362,467
2026-02-09 (Monday)	3,942	USD 357,973	USD 357,973	0	USD -9,697	USD 90.81	USD 93.2699
2026-02-06 (Friday)	3,942	USD 367,670	USD 367,670	0	USD 50,339	USD 93.2699	USD 80.5
2026-02-02 (Monday)	3,942	USD 317,331	USD 317,331	0	USD 6,859	USD 80.5	USD 78.76
2026-01-30 (Friday)	3,942	USD 310,472	USD 310,472	0	USD 315	USD 78.76	USD 78.6801
2026-01-29 (Thursday)	3,942	USD 310,157	USD 310,157	0	USD -1,024	USD 78.6801	USD 78.9399
2026-01-28 (Wednesday)	3,942	USD 311,181	USD 311,181	0	USD -10,407	USD 78.9399	USD 81.5799
2026-01-27 (Tuesday)	3,942	USD 321,588	USD 321,588	0	USD -552	USD 81.5799	USD 81.7199
2026-01-26 (Monday)	3,942	USD 322,140	USD 322,140	0	USD -3,706	USD 81.7199	USD 82.6601

Share Trades of MLAB by Blackrock for IE00BKTLJC87

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-12-12	SELL	-93	79.905	77.355	77.610	USD -7,218	105.53 Profit of 2,596 on sale
2025-10-28	SELL	-93	77.910	79.190	79.062	USD -7,353	110.28 Profit of 2,904 on sale
2025-09-30	BUY	93	67.010	67.300	67.271	USD 6,256	113.19
2025-09-24	SELL	-93	66.410	70.570	70.154	USD -6,524	114.25 Profit of 4,100 on sale
2025-08-12	SELL	-93	63.270	63.780	63.729	USD -5,927	116.13 Profit of 4,873 on sale
2025-07-07	BUY	311	92.940	102.430	101.481	USD 31,561	119.90
2025-04-08	SELL	-86	105.240	115.060	114.078	USD -9,811	127.03 Profit of 1,114 on sale
2025-04-07	SELL	-172	109.040	113.770	113.297	USD -19,487	127.22 Profit of 2,394 on sale
2025-04-02	SELL	-86	120.690	121.910	121.788	USD -10,474	127.49 Profit of 490 on sale
2025-03-06	SELL	-86	138.210	139.140	139.047	USD -11,958	128.03 Loss of -948 on sale
2025-03-05	SELL	-86	137.550	141.750	141.330	USD -12,154	127.90 Loss of -1,155 on sale
2024-12-30	SELL	-86	132.040	133.120	133.012	USD -11,439	118.00 Loss of -1,291 on sale
2024-12-05	SELL	-86	123.000	125.500	125.250	USD -10,772	117.10 Loss of -701 on sale

Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of MLAB

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy